Gilead Sciences, Inc.
—- Market cap
- $178.33B
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
GILD · price snapshotP/E 21.21x
$143.82Snapshot Sep 11, 2026, 3:53 PM ET
Implied fair value · at CLX's multiple
$90.8936.8% below market
6.78 GILD Annual EPS×13.40x CLX P/E=$90.89
Market $143.82Implied $90.89
CLX · price snapshotP/E 13.40x
$87.40Snapshot Sep 11, 2026, 3:53 PM ET
Implied fair value · at GILD's multiple
$138.3058.2% above market
6.52 CLX Annual EPS×21.21x GILD P/E=$138.30
Market $87.40Implied $138.30